查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1235928

全球連續性腎臟替代療法市場：到 2028 年的預測——按產品、方式、年齡組、最終用戶和地區分類

Continuous Renal Replacement Therapy Market Forecasts to 2028 - Global Analysis By Product, Modality, Age Group, End User and Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球持續性腎臟替代療法 (CRRT) 市場將在 2022 年達到 13.1 億美元，到 2028 年達到 22.3 億美元，預計在此期間以 9.3% 的複合年增長率增長預測期。

連續性腎臟替代療法 (CRRT) 是急性腎損傷 (AKI) 重症患者的常用治療方法，尤其是那些血流動力學不穩定的患者。 它涉及通過血液濾過、血液透析或兩者結合從血液中去除溶質的過程。

根據美國醫院協會的數據，2021 年將有 208 家聯邦醫院、625 家非聯邦精神病醫院和 5,141 家社區醫院。 此外，由於AKI住院患者的顯著增加和老年人口的增加，對CRRT系統的需求也在增加，這是市場擴張的驅動力。

市場動態

驅動程序

急性腎損傷和慢性腎病增加

急性腎功能衰竭的主要危險因素是糖尿病、高血壓和衰老。 糖尿病的患病率在全球範圍內迅速上升。 因此，隨著糖尿病的流行，急性腎功能衰竭患者的數量也在增加。 醫護人員意識的提高有望遏制急性腎損傷的發生，加強對老年人基礎疾病的管理。

抑製劑

治療費用高

新興國家/地區的人們更喜歡購買低價商品，因為他們看重購買能力。 儘管發展中國家的成本很高，但許多人的低購買力使他們無法採取此類措施。 這限制了發達國家和發展中國家對該療法的需求和採用。

機會

新技術介紹

設備設計的技術進步極大地促進了危重患者的治療。 這些技術創新大大擴展了 ICU 體外治療的範圍。 此外，軟件集成很可能成為最先進機器的全新工具。

威脅

嚴格的醫療保健法規

由於公司受制於許多現有的法律法規，它們很容易受到監管環境變化的影響，不合規很可能對其運營、財務狀況和業務產生不利影響。 作為醫療保健行業的進入者，讓貴公司的運營和產品受制於各種政府法規會阻礙市場擴張。

COVID-19 的影響

COVID-19 的總體影響對市場仍然是積極的。 大流行顯著增加了全球對腎臟替代液的需求。 與過去的美國人口相比，COVID-19 患者對 RRT 的需求增加了五倍。 例如，在中國和意大利，據報導 AKI 發生率高達 29%（國際腎髒病學會研究 2020）。 及早實施連續性腎臟替代治療 (CRRT) 對於降低 AKI 的發病率很重要，AKI 因 COVID-19 感染而增加。

連續靜脈血液濾過療法 (CVVHDF) 預計在預測期內將成為最大的細分市場

由於透析治療的增加，估計連續靜脈血液濾過 (CVVHDF) 部分有良好的增長。 這種治療涉及全面去除和更換血液中的溶質和液體。 它還包括擴散和對流的原理，從而促進了市場的增長。

預計在預測期內，成年人的複合年增長率最高。

由於各種監管批准和新產品開發的增加，預計在預測期內成人將以最快的複合年增長率增長。 此外，不同市場參與者採用不同的增長策略也為該行業創造了有利可圖的機會。

市場份額最高的地區

由於技術進步和醫療保健支出增加，亞太地區預計在預測期內將佔據最大的市場份額。 這主要是由於加大了對產品研發的投入力度。 此外，主要製造商注重擴大地域分佈也是推動該地區增長的一個因素。

複合年增長率最高的地區

由於老年人口增加和急性腎損傷增加，預計歐洲在預測期內的複合年增長率最高。 連續性腎臟替代療法新技術的高采用率和完善的醫療基礎設施的存在顯著推動了該地區的市場增長。

市場主要公司

連續性腎臟替代療法 (CRRT) 市場的主要參與者是： Asahi Kasei Corporation, B. Braun Medical Inc., Baxter International Inc., Chongqing Shanwaishan Science and Technology Co, Ltd., Fresenius Medical Care AG & Co.KGaA, Infomed SA, Medica SpA, Medical Components, Inc. , Medites Pharma Spol.S.R.O., Medtronic Plc, Nikkiso Co., Ltd., Ningbo Tianyi Medical Appliance Co., Ltd., NIPRO Corporation, NxStage Medical, Inc., Toray Medical Co., Ltd.

主要發展

2021 年 2 月，DaVita 通過將其安全的遠程醫療平台 DaVita Care Connect 納入其家庭透析計劃，取得了第一名。 它是該公司服務套件中的一系列互聯技術之一，旨在改善決定在家接受治療的患者的治療結果和護理體驗。

2020 年 12 月，美敦力公司宣布推出 Carpe Diem Cardiac Renal Pediatric Dialysis Emergency Unit。 該程序適用於需要血液透析的急性腎損傷和體液超負荷的患者。 它將為體重在 2.5 至 10 公斤之間的患者提供持續性腎臟替代療法 (CRRT)。

2020 年 4 月，全球透析產品和服務提供商 Fresenius Medical Care 宣布已發布諮詢，呼籲在大流行危機期間為晚期慢性腎病患者提供臨床護理原則。. 該諮詢還指出，在 COVID-19 危機期間需要腎臟替代治療的患者也應接受與其醫生協商後確定的治療。

我們的報告提供了什麼

  • 區域和國家級細分市場的市場份額評估
  • 向新進入者提出戰略建議
  • 2020、2021、2022、2025 和 2028 年的綜合市場數據
  • 市場驅動因素（市場趨勢、制約因素、機遇、威脅、挑戰、投資機會/建議等）
  • 根據市場預測在關鍵業務領域提出戰略建議
  • 競爭格局和趨勢
  • 公司簡介，包括詳細的戰略、財務狀況和近期發展
  • 供應鏈趨勢反映了最新的技術進步。

提供免費定制

購買此報告的客戶將免費獲得以下定制之一。

  • 公司簡介
    • 其他市場公司的綜合概況（最多 3 人）
    • 關鍵公司的 SWOT 分析（最多 3 人）
  • 區域細分
    • 應客戶要求提供主要國家/地區的市場估算、預測和復合年增長率（注意：通過可行性檢查）
  • 競爭基準

根據產品組合、地理分佈和戰略聯盟對主要參與者進行基準測試

目錄

第 1 章執行摘要

第二章前言

  • 概覽
  • 利益相關者
  • 調查範圍
  • 調查方法
    • 數據挖掘
    • 數據分析
    • 數據驗證
    • 研究方法
  • 調查來源
    • 主要研究信息來源
    • 二手研究資源
    • 假設

第三章市場趨勢分析

  • 司機
  • 約束因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第 5 章全球連續性腎臟替代療法 (CRRT) 市場：按產品分類

  • 透析液和置換液
  • 一次性用品
  • 血液過濾器
  • 系譜套裝和試管
  • CRRT系統
  • 其他產品

第 6 章全球連續性腎臟替代療法 (CRRT) 市場：按方式分類

  • 低速連續超濾 (SCUF)
  • 連續靜脈血液濾過 (CVVH)
  • 連續性靜脈血液透析 (CVVHD)
  • 連續靜脈血液透析濾過 (CVVHDF)

第 7 章全球持續性腎臟替代治療 (CRRT) 市場：按年齡組分類

  • 成人
  • 兒科/新生兒科

第 8 章全球連續性腎臟替代療法 (CRRT) 市場：按最終用戶分類

  • 醫院
  • 門診中心
  • 專科診所
  • 其他最終用戶

第 9 章全球連續性腎臟替代療法 (CRRT) 市場：區域

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 意大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 新西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中東和非洲
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 卡塔爾
    • 南非
    • 其他中東地區

第10章主要發展

  • 合同、夥伴關係、協作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章公司簡介

  • Asahi Kasei Corporation
  • B. Braun Medical Inc.
  • Baxter International Inc.
  • Chongqing Shanwaishan Science and Technology Co., Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • Infomed SA
  • Medica SpA
  • Medical Components, Inc.
  • Medites Pharma Spol. S.R.O.
  • Medtronic PLC
  • Nikkiso Co., Ltd.
  • Ningbo Tianyi Medical Appliance Co., Ltd
  • NIPRO Corporation
  • NxStage Medical, Inc.
  • Toray Medical Co., Ltd.
Product Code: SMRC22525

According to Stratistics MRC, the Global Continuous Renal Replacement Therapy (CRRT) Market is accounted for $1.31 billion in 2022 and is expected to reach $2.23 billion by 2028 growing at a CAGR of 9.3% during the forecast period. A common form of treatment for critically ill patients with acute kidney injury (AKI), particularly those with unstable hemodynamics, is continuous renal replacement therapy (CRRT). It includes the process of removing solutes from blood via hemofiltration, hemodialysis, or a combination of the two.

According to the American Hospital Association, there were 208 federal government hospitals, 625 nonfederal psychiatric hospitals, and 5,141 community hospitals in the country in 2021. The demand for CRRT systems is also rising due to the significant rise in AKI hospital admissions and the growing geriatric population, which is fueling market expansion.

Market Dynamics:

Driver:

Increase in acute kidney injury and chronic kidney diseases

The main risk factors for acute kidney injury are diabetes, hypertension, and an ageing population. Diabetes prevalence is rising quickly across the globe. As a result, the number of patients with acute kidney injury is growing along with the prevalence of diabetes. Growing awareness among medical professionals could lessen its occurrence and enhance the management of underlying diseases in the elderly population.

Restraint:

High procedural cost

People in emerging economies value affordability, so they favour lower-cost goods. Despite the high cost in developing nations, a large portion of the population cannot afford these measures because of their low purchasing power. This restricts both the developed and developing world's demand for and adoption of this therapy.

Opportunity:

Implementation of new technologies

Technology advancements in equipment design have greatly benefited the use of therapy in critically ill patients. These innovations have significantly broadened the scope of extracorporeal therapies in the ICU. Additionally, software integration is likely to emerge as a brand-new tool for cutting-edge machinery.

Threat:

Stringent healthcare regulations

Companies are vulnerable to a changing regulatory environment because they are subject to a number of existing laws and regulations, and non-compliance will likely have a negative impact on their operations, financial condition, and business. The fact that businesses' operations and goods are subject to a variety of government regulations as healthcare industry participants is a hindrance to the market's expansion.

COVID-19 Impact:

The overall impact of COVID-19 remains positive on the market. The pandemic has significantly increased the demand for renal replacement fluids on a global scale. When compared to historical US populations, the demand for RRT among COVID-19 patients has increased five times. China and Italy, for example, reported AKI rates as high as 29%, according to a study by the International Society of Nephrology 2020. Early implementation of continuous renal replacement therapy (CRRT) is crucial for reducing the incidence of AKI, which is on the rise as a result of COVID-19 infection.

The Continuous Venovenous Hemodiafiltration (CVVHDF) segment is expected to be the largest during the forecast period

The continuous venovenous hemodiafiltration (CVVHDF) segment is estimated to have a lucrative growth, due to the increase in dialysis procedures. This treatment modality results in comprehensive removal and replacement of solutes and fluids within the blood. It also includes principles of diffusion and convection, hence propelling the growth of the market.

The Adults segment is expected to have the highest CAGR during the forecast period

The adults segment is anticipated to witness the fastest CAGR growth during the forecast period, due to various regulatory approvals for adult and rise in development of novel products. Additionally, adoption of various growth strategies by various market players are creating lucrative opportunities in the segment.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to rising technological advancement, surging healthcare expenditure. This is primarily attributed to increase in number of initiatives along with enhanced investments for the overall R&D of products. Additionally, surge in focus of leading manufacturers on expanding their geographical presence is the factor driving the region growth.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to rise in geriatric population and increasing incidences of acute kidney injury. High adoption rates of new technologies in continuous renal replacement therapy and the presence of well-established healthcare infrastructure is fueling the growth of the overall regional market to a large extent.

Key players in the market

Some of the key players in Continuous Renal Replacement Therapy (CRRT) market include: Asahi Kasei Corporation, B. Braun Medical Inc., Baxter International Inc., Chongqing Shanwaishan Science and Technology Co., Ltd., Fresenius Medical Care AG & Co. KGaA, Infomed SA, Medica SpA, Medical Components, Inc., Medites Pharma Spol. S.R.O., Medtronic Plc, Nikkiso Co., Ltd., Ningbo Tianyi Medical Appliance Co., Ltd, NIPRO Corporation, NxStage Medical, Inc. and Toray Medical Co., Ltd.

Key Developments:

In February 2021, DaVita accomplished its first position by including a secure telehealth platform, DaVita Care Connect, into its home dialysis program. It is one of the various connective technologies in its suite of services designed to improve outcomes and the care experience for patients deciding to treat at home.

In December 2020, Medtronic plc announced the launch of the Carpediem Cardio-Renal Pediatric Dialysis Emergency Machine. This technique is indicated to be used in acute kidney injury or fluid overloaded patients that need hemodialysis. It is planned to supply continuous renal replacement therapy (CRRT) to patients weighing between 2.5 & 10 kg.

In April 2020, Fresenius Medical Care, a worldwide provider of dialysis products and services, has announced the release of an advisory that calls for clinical care principles for patients with advanced chronic kidney during the pandemic crisis. The advisory states that patients who need renal replacement therapy during the COVID-19 crisis should still be offered the treatment decided in consultation with their physicians.

Products Covered:

  • Dialysates and Replacement Fluids
  • Disposables
  • Hemofilters
  • Bloodline Sets & Tubes
  • CRRT Systems
  • Other Products

Modalities Covered:

  • Slow Continuous Ultra-Filtration (SCUF)
  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)

Age Groups Covered:

  • Adults
  • Pediatrics /Neonates

End Users Covered:

  • Hospitals
  • Ambulatory Centers
  • Specially Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking

Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Continuous Renal Replacement Therapy (CRRT) Market, By Product

  • 5.1 Introduction
  • 5.2 Dialysates and Replacement Fluids
  • 5.3 Disposables
  • 5.4 Hemofilters
  • 5.5 Bloodline Sets & Tubes
  • 5.6 CRRT Systems
  • 5.7 Other Products

6 Global Continuous Renal Replacement Therapy (CRRT) Market, By Modality

  • 6.1 Introduction
  • 6.2 Slow Continuous Ultra-Filtration (SCUF)
  • 6.3 Continuous Venovenous Hemofiltration (CVVH)
  • 6.4 Continuous Venovenous Hemodialysis (CVVHD)
  • 6.5 Continuous Venovenous Hemodiafiltration (CVVHDF)

7 Global Continuous Renal Replacement Therapy (CRRT) Market, By Age Group

  • 7.1 Introduction
  • 7.2 Adults
  • 7.3 Pediatrics /Neonates

8 Global Continuous Renal Replacement Therapy (CRRT) Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Ambulatory Centers
  • 8.4 Specially Clinics
  • 8.5 Other End Users

9 Global Continuous Renal Replacement Therapy (CRRT) Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Asahi Kasei Corporation
  • 11.2 B. Braun Medical Inc.
  • 11.3 Baxter International Inc.
  • 11.4 Chongqing Shanwaishan Science and Technology Co., Ltd.
  • 11.5 Fresenius Medical Care AG & Co. KGaA
  • 11.6 Infomed SA
  • 11.7 Medica SpA
  • 11.8 Medical Components, Inc.
  • 11.9 Medites Pharma Spol. S.R.O.
  • 11.10 Medtronic PLC
  • 11.11 Nikkiso Co., Ltd.
  • 11.12 Ningbo Tianyi Medical Appliance Co., Ltd
  • 11.13 NIPRO Corporation
  • 11.14 NxStage Medical, Inc.
  • 11.15 Toray Medical Co., Ltd.

List of Tables

  • Table 1 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
  • Table 3 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
  • Table 4 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
  • Table 5 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
  • Table 6 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
  • Table 7 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
  • Table 8 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 9 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
  • Table 10 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
  • Table 11 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
  • Table 12 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
  • Table 13 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
  • Table 14 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
  • Table 15 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
  • Table 16 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
  • Table 17 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
  • Table 18 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 19 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
  • Table 20 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
  • Table 21 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 22 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
  • Table 23 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
  • Table 24 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
  • Table 25 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
  • Table 26 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
  • Table 27 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
  • Table 28 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
  • Table 29 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 30 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
  • Table 31 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
  • Table 32 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
  • Table 33 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
  • Table 34 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
  • Table 35 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
  • Table 36 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
  • Table 37 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
  • Table 38 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
  • Table 39 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 40 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
  • Table 41 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
  • Table 42 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 43 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
  • Table 44 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
  • Table 45 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
  • Table 46 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
  • Table 47 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
  • Table 48 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
  • Table 49 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
  • Table 50 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 51 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
  • Table 52 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
  • Table 53 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
  • Table 54 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
  • Table 55 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
  • Table 56 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
  • Table 57 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
  • Table 58 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
  • Table 59 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
  • Table 60 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 61 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
  • Table 62 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
  • Table 63 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 64 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
  • Table 65 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
  • Table 66 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
  • Table 67 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
  • Table 68 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
  • Table 69 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
  • Table 70 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
  • Table 71 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 72 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
  • Table 73 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
  • Table 74 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
  • Table 75 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
  • Table 76 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
  • Table 77 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
  • Table 78 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
  • Table 79 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
  • Table 80 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
  • Table 81 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 82 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
  • Table 83 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
  • Table 84 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 85 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
  • Table 86 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
  • Table 87 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
  • Table 88 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
  • Table 89 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
  • Table 90 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
  • Table 91 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
  • Table 92 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 93 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
  • Table 94 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
  • Table 95 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
  • Table 96 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
  • Table 97 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
  • Table 98 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
  • Table 99 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
  • Table 100 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
  • Table 101 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
  • Table 102 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 103 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
  • Table 104 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
  • Table 105 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 106 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
  • Table 107 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
  • Table 108 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
  • Table 109 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
  • Table 110 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
  • Table 111 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
  • Table 112 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
  • Table 113 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 114 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
  • Table 115 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
  • Table 116 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
  • Table 117 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
  • Table 118 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
  • Table 119 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
  • Table 120 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
  • Table 121 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
  • Table 122 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
  • Table 123 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 124 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
  • Table 125 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
  • Table 126 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)